Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%

人工智能 · 综合与其他 · us · 来源:Ars Technica · 2026-10-22 22:12

Markers released top-line results today after previously reporting the trial succeeded.

关键词:综合

原文链接:https://arstechnica.com/health/2026/10/personalized-mrna-cancer-vaccine-cut-melanoma-death-recurrence-by-42/

本页由情报雷达 INFO RADAR 采集整理,引用请注明来源「情报雷达 INFO RADAR」并附链接 https://intel.zovaxai.com/i/2666151993d33bff。

← 返回 · 情报雷达首页 · 今日情报快照